South Australian researchers working with Oracle Cloud technology and vaccine technology developed by local company Vaxine Pty Ltd are testing a vaccine candidate against the SARS-CoV-2 coronavirus responsible for the COVID-19 pandemic.
The team is headed by Nikolai Petrovsky, Flinders University Professor and Research Director at Vaxine.
His team has tapped Oracle for technical collaboration, access to an expanded research community, and cloud infrastructure that helped enable the rapid design of the novel COVID-19 vaccine candidate.
“The vaccine has progressed into animal testing in the US and, once we confirm it is safe and effective, will then be advanced into human trials,” says Professor Petrovsky – stressing expectations shouldn’t be elevated until all testing is completed.
The latest cloud-based technology provided by Oracle enabled the team to “dramatically speed up our ability to analyse the COVID-19 virus and use this information to design the vaccine candidate”.
“As soon as the genomic sequence of COVID-19 became available in January, we immediately used this, combined with our previous experience in developing a SARS coronavirus vaccine, to characterise the key viral attachment molecule called the spike protein,” Professor Petrovsky says.
“We used computer models of the spike protein and its human receptor, ACE2, to identify how the virus was infecting human cells, and then were able to design a vaccine to block this process,” he says.
Flinders University Associate Professor Dimitar Sajkov, a respiratory physician in South Australia, has been involved in conducting previous human trials of the team’s pandemic vaccines and hopes to similarly lead clinical trials of this new COVID-19 vaccine candidate.
“The team has exploited the very latest technologies, including AI, advanced manufacturing and Cloud computing to accelerate vaccine design, shaving years off normal development timeframes,” Professor Sajkov says.
“We achieved great results with Vaxine’s swine flu vaccine developed during the 2009 swine flu pandemic, where we commenced clinical trials of a vaccine within 3 months of discovery of the virus. We hope to achieve similar results with their COVID-19 vaccine candidate when it is ready for human testing,” he says.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Some states plan to vet Covid-19 vaccines themselves. Bad idea, experts say.on October 7, 2020 at 2:12 am
California and at least five other states have said they may independently vet any vaccines, but experts warn that could needlessly confuse the public.
- White House approves new COVID-19 vaccine standards after FDA publishes them anywayon October 7, 2020 at 1:51 am
The White House on Tuesday, in an apparent reversal, approved stringent new Food and Drug Administration guidelines for emergency use approval of a COVID-19 vaccine. The Trump administration was ...
- China's experimental COVID-19 vaccine appears safe - studyon October 7, 2020 at 12:20 am
A Chinese experimental coronavirus vaccine being developed by the Institute of Medical Biology under the Chinese Academy of Medical Sciences was shown to be safe in an early stage clinical trial, ...
- US Agency Wants 2 Months Safety Data Before Approving Covid-19 Vaccineon October 6, 2020 at 11:16 pm
The US Food and Drug Administration made public its guidance for issuing emergency approval for a Covid-19 vaccine on Tuesday, making it clear it wants to see follow-up two months after trial ...
- President Donald Trump says COVID-19 vaccines are coming 'momentarily.' Scientists say they're not.on October 6, 2020 at 9:09 pm
President Donald Trump said COVID-19 vaccines Are coming "momentarily." Doctors and scientists have repeatedly refuted that claim.
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- Arizona state Rep. Lorenzo Sierra hospitalized with COVID-19; lawmaker in ICU, intubatedon October 7, 2020 at 2:35 am
A spokesperson for House Democrats said Sierra was hospitalized Sunday evening and taken to The Johns Hopkins Hospital in Baltimore ...
- Trump's COVID-19 Treatment Hangs Over Vice Presidential Debateon October 7, 2020 at 2:05 am
Vice President Mike Pence and Democratic vice presidential nominee Kamala Harris have their only debate Wednesday in Salt Lake City. Amid the White House COVID-19 outbreak, the stage has changed.
- Donald Trump's COVID-19 treatment is similar to the average American hospitalized with coronavirus. Only faster.on October 7, 2020 at 12:22 am
President Trump received mostly the same treatment as anyone would get for COVID-19, except for one experimental drug and the speed of his care.
- Dexamethasone: Here Are The Side Effects Of The Covid-19 Coronavirus Treatment That Trump Receivedon October 6, 2020 at 10:42 pm
Dexamethasone has shown promise in decreasing the risk of death for patients with more severe Covid-19 coronavirus infections. But getting dexamethasone isn’t like eating baked ziti. Corticosteroids ...
- Yale doctor on Trump's COVID-19 treatment and health conditionon October 6, 2020 at 8:53 pm
President Trump is back at the White House but his doctors are warning he is "not out of the woods" yet. Dr. James Hamblin is a lecturer at the Yale School of Public Health, staff writer at The ...